Kampanjeplan Legend Biotech Corporation
Avansert tidsplan
Enkel graf
Om selskapet
Legend Biotech Corporation, биофармацевтическая компания, работающая на клинической стадии, занимается открытием и разработкой новых клеточных методов лечения онкологии и других показаний. Его главный кандидат в продукте, LCAR-B38M \ u002FJNJ-4528, представляет собой аутологичную терапию CAR-T-клетками, нацеленную на антиген созревания B-клеток. Компания проводит несколько клинических испытаний для оценки LCAR-B38M \ u002FJNJ-4528 в качестве более ранней линии терапии множественной миеломы (ММ), а также сравнение лечения со стандартной триплетной терапией при ММ, резистентном к ревлимиду. flere detaljerIPO date | 2020-06-05 |
---|---|
ISIN | US52490G1022 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.legendbiotech.com |
Цена ао | 33.62 |
Prisendring per dag: | 0% (33.62) |
---|---|
Prisendring per uke: | -3.17% (34.72) |
Prisendring per måned: | -5.27% (35.49) |
Prisendring over 3 måneder: | -32.33% (49.68) |
Prisendring over seks måneder: | -38.87% (55) |
Prisendring per år: | -44.68% (60.77) |
Prisendring over 3 år: | -19.18% (41.6) |
Prisendring over 5 år: | 0% (33.62) |
Prisendring over 10 år: | 0% (33.62) |
Prisendring siden begynnelsen av året: | +2.5% (32.8) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Transaksjonsdato | Avsløringsdato | Insider | Type | Pris | Volum | Mengde | Del opp til, % | Del etterpå, % | Dokument |
---|---|---|---|---|---|---|---|---|---|
10.01.2025 | 10.01.2025 | Macomber Lori Former Officer |
Kjøpe | 32.19 | 72 556 | 2254 | 0 | 0 | link |
02.12.2024 | 02.12.2024 | Heyman Tomas J. Director |
Kjøpe | 43.31 | 189 091 | 4366 | 0 | 0 | link |
25.09.2024 | 25.09.2024 | Huang Ying Officer |
Kjøpe | 44.1 | 66 326 | 1504 | 0 | 0 | link |
Institusjoner | Volum | Dele, % |
---|---|---|
FMR, LLC | 12797994 | 7.04 |
Price (T.Rowe) Associates Inc | 10808216 | 5.94 |
RA Capital Management, L.P. | 6264707 | 3.44 |
HHLR Advisors, LTD | 5984550 | 3.29 |
Blackrock Inc. | 5266188 | 2.89 |
Capital World Investors | 2385960 | 1.31 |
Wellington Management Group, LLP | 2306391 | 1.27 |
Massachusetts Financial Services Co. | 1984826 | 1.09 |
Paradigm Biocapital Advisors LP | 1894644 | 1.04 |
Janus Henderson Group PLC | 1865157 | 1.03 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Dr. Ying Huang Ph.D. | CEO & Director | N/A | 1973 (52 år) |
Joanne Choi | Senior Manager of Investor Relations | N/A | |
Dr. Guowei Fang Ph.D. | Chief Scientific Officer & Head of Business Development | N/A | |
Mr. James Pepin J.D. | General Counsel | N/A | |
Mr. Doug Wallace | Vice President of Global Operations | N/A | |
Ms. Lori A. Macomber CPA | Chief Financial Officer | 1971 (54 år) | |
Mr. Tim Roberts | Global Compliance Officer | ||
Deborah Wong | Executive Director of Strategic Marketing & Corporate Communications | ||
Ms. Elaine Qian | VP & Global Head of Human Resources | ||
Dr. Yuhong Qiu Ph.D. | Senior Vice President of Global Regulatory Affairs |
Adresse: United States, Somerset, NJ , 2101 Cottontail Lane - åpne i Google maps, åpne Yandex-kart
Nettsted: http://www.legendbiotech.com
Nettsted: http://www.legendbiotech.com